参考文献/References:
［1］ DU X,PATEL A,ANDERSON C S,et al.Epidemiology of cardiovascular disease in China and opportunities for improvement:JACC international［J］.J Am Coll Cardiol,2019,73(24):3135-3147.
［2］ NGUYEN N,CANSECO D C,FENG X,et al.A calcineurin-Hoxb13 axis regulates growth mode of mammalian cardiomyocytes［J］.Nature,2020,582(7811):1-6.
［3］ LEI M M.In vivo elongation of thin filaments results in heart failure［J］.PLoS One,2020,15(1):e0226138.
［4］ GONZALEZ A,SCHELBERT E B,DIEZ J,et al.Myocardial interstitial fibrosis in heart failure:biological and translational perspectives［J］.J Am Coll Cardiol,2018,71(15):1696-1706.
［5］ MICHLEWSKI G P,CACERES J F.Post-transcriptional control of miRNA biogenesis［J］.RNA,2018,25(1):068692.
［6］ SALIMINEJAD K,KHORRAM KHORSHID H R,SOLEYMANI FARD S,et al.An overview of microRNAs:biology,functions,therapeutics,and analysis methods［J］.J Cell Physiol,2019,234(5):5451-5465.
［7］ AKMAK H A,DEMIR M.MicroRNA and cardiovascular diseases［J］.Balkan Med J,2020,37(2):60-71.
［8］ REMSBURG C,KONRAD K,SAMPILO N F,et al.Analysis of microRNA functions［J］.Methods Cell Biol,2019,151:323-334.
［9］ HUANG C K,KAFERT-KASTING S,THUM T.Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease［J］.Circ Res,2020,126(5):663-678.
［10］ HUANG Y.The novel regulatory role of incRNA-miRNA-mRNA axis in cardiovascular diseases［J］.J Cell Mol Med,2018,22(12):5768-5775.
［11］ LIN F,ZHAO G,CHEN Z,et al.CircRNA miRNA association for coronary heart disease［J］.Mol Med Rep,2019，19(4):2527-2536.
［12］ 林飞,赵国安,陈志刚,等.急性心肌梗死circRNA-miRNA网络相关性及可能调控机制分析［J］.中华医学杂志,2018,98(11):851-854.
［13］ LU Y,THAVARAJAH T,GU W,et al.Impact of miRNA in atherosclerosis［J］.Arterioscler Thromb Vasc Biol,2018,38(9):e159-e170.
［14］ ZHOU S S,JIN J P,WANG J Q,et al.miRNA in cardiovascular diseases:potential biomarkers,therapeutic targets and challenges［J］.Acta Pharmacol Sin,2018,39(7):1073-1084.
［15］ ZHAO G.Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases［J］.J Med Genet,2018,55(11):713-720.
［16］ NAGY O,BARATH S,UJFALUSI A.The role of microRNAs in congenital heart disease［J］.EJIFCC,2019,30:165-178.
［17］ BAYES-GENIS A,LANFEAR D E,RONDE M,et al.Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients［J］.Eur J Heart Fail,2018,20(1):67-75.
［18］ NIE X,FAN J,LI H,et al.MiR-217 promotes cardiac hypertrophy and dysfunction by targeting PTEN［J］.Mol Ther Nucleic Acids,2018,12:254-266.
［19］ ZHANG M,JIANG Y,GUO X,et al.Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway［J］.J Cell Mol Med,2019,23(11):7685-7698.
［20］ IKEDA S,HE A,KONG S W,et al.MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes［J］.Mol Cell Biol,2009,29(8):2193-2204.
［21］ KOPECHEK J A,MCTIERNAN C F,CHEN X,et al.Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function［J］.Theranostics,2019,9(23):7088-7098.
［22］ LV L,LI T,LI X,et al.The lncRNA Plscr4 controls cardiac hypertrophy by regulating miR-214［J］.Mol Ther Nucleic Acids,2018,10:387-397.
［23］ SASSI Y,AVRAMOPOULOS P,RAMANUJAM D,et al.Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling［J］.Nat Commun,2017,8(1):1614.
［24］ HUANG C Y,PAI P Y,KUO C H,et al.p53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure［J］.Cell Death Dis,2017,8(8):e2990.
［25］ WANG Q,YU X,DOU L,et al.MiR-154-5p functions as an important regulator of angiotensin II-mediated heart remodeling［J］.Oxid Med Cell Longev,2019,2019:8768164.
［26］ BERNARDO B C,NGUYEN S S,GAO X M,et al.Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload［J］.Sci Rep,2016,6:22442.
［27］ FENG B,CHEN S,GORDON A D,et al.MiR-146a mediates inflammatory changes and fibrosis in the heart in diabetes［J］.J Mol Cell Cardiol,2017,105:70-76.
［28］ CHIASSON V,TAKANO A P C,GULERIA R S,et al.Deficiency of microRNA miR-1954 promotes cardiac remodeling and fibrosis［J］.J Am Heart Assoc,2019,8(21):e012880.
［29］ PAN Z,SUN X,SHAN H,et al.MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway［J］.Circulation,2012,126(7):840-850.
［30］ ZHANG Y,WANG J H,ZHANG Y Y,et al.Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGF-β1 and miR-29 pathways［J］.Sci Rep,2016,6:23010.
［31］ LIU X,DENG Y,XU Y,et al.MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1［J］.J Mol Cell Cardiol，2018,118:133-146.
［32］ LI Z,SONG Y,LIU L,et al.MiR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation［J］.Cell Death Differ,2017,24(7):1205-1213.
［33］ ZOU M,WANG F,GAO R,et al.Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts［J］.Sci Rep,2016,6:24747.
［34］ HU J,HUANG C X,RAO P P,et al.MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation［J］.Eur J Pharmacol,2019,857:172449.
［35］ HOU W,ZHU X,LUI J,et al.Inhibition of miR-153 ameliorates ischemia/reperfusion-induced cardiomyocytes apoptosis by regulating Nrf2/HO-1 signaling in rats［J］.Biomed Eng Online,2020,19(1):15.
［36］ YANG Q H,YANG M,ZHANG L L,et al.The mechanism of miR-23a in regulating myocardial cell apoptosis through targeting FoxO3［J］.Eur Rev Med Pharmacol Sci,2017,21(24):5789-5797.
［37］ LAVINE K J,PIN A R,EPELMAN S,et al.The macrophage in cardiac homeostasis and disease:JACC macrophage in CVD series (Part 4)［J］.J Am Coll Cardiol,2018,72(18):2213-2230.
［38］ COUTO G,GALLET R,CAMBIER L,et al.Exosomal microRNA transfer into macrophages mediates cellular postconditioning［J］.Circulation,2017,136(2):200-214.
［39］ BEJERANO T,ETZIN S,ELYAGONl S,et al.Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction［J］.Nano Lett,2018,18(9):5885-5891.
［40］ KUMAR A A,KELLY D P,CHIRINOS J A.Mitochondrial dysfunction in heart failure with preserved ejection fraction［J］.Circulation,2019,139(11):1435-1450.
［41］ ZHOU B,TIANIAN R.Mitochondrial dysfunction in pathophysiology of heart failure［J］.J Clin Invest,2018,128(9):3716-3726.
［42］ HEGGERMONT W A,PAPAGEORGIOU A P,QUAEGEBEUR A,et al.Inhibition of microRNA-146a and overexpression of its target dihydrolipoyl succinyltransferase protect against pressure overload-induced cardiac hypertrophy and dysfunction［J］.Circulation,2017,136(8):747-761.
［43］ SUN W,ZHAO L,SONG X,et al.MicroRNA-210 modulates the cellular energy metabolism shift during H2O2-induced oxidative stress by repressing ISCU in H9c2 cardiomyocytes［J］.Cell Physiol Biochem,2017,43(1):383-394.
［44］ LAHEY R,CARLEY A N,WANG X,et al.Enhanced redox state and efficiency of glucose oxidation with miR based suppression of maladaptive NADPH-dependent malic enzyme 1 expression in hypertrophied hearts［J］.Circ Res,2018,122(6):836-845.
［45］ WANG H,BEI Y,SHEN S,et al.MiR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2［J］.J Mol Cell Cardiol,2016,94:43-53.
［46］ DAS S,KOHR M,DUNKERLY-EYRING B,et al.Divergent effects of miR-181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets［J］.J Am Heart Assoc,2017,6(3):e004694.
［47］ AZZOUZI H,LEPTIDIS S,DIRKX E,et al,The hypoxia-inducible microRNA cluster miR-199a~214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation［J］.Cell Metab,2013,18(3):341-354.
［48］ SUN W,ZHAO L,SONG X,et al.MicroRNA-210 modulates the cellular energy metabolism shift during H2O2-induced oxidative stress by repressing ISCU in H9c2 cardiomyocytes［J］.Cell Physiol Biochem,2017,43(1):383-394.
［49］ GUAN X,WANG L,LIU Z,et al.MiR-106a promotes cardiac hypertrophy by targeting mitofusin 2［J］.J Mol Cell Cardiol,2016,99:207-217.
［50］ BLUMENSATT M,FAHLUUSCH P,HILGERS R,et al.Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a［J］.Basic Res Cardiol,2017，112(1):2.